NYSE$IEX

IDEX Corp · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

IDEX's second quarter earnings declined due to the impact of the global health pandemic, but the company showed resilience with strong operating performance and new product development.

IDEX Corporation reported a decrease in sales and earnings for the second quarter of 2020, impacted by the global health pandemic. However, the company demonstrated resilience with strong operating performance and the development of new products to support the fight against COVID-19. The company achieved record quarterly free cash flow and ended the quarter with a strong cash position.

  • Second quarter orders were down 17 percent compared to the prior year period.
  • Sales were down 13 percent compared to the prior year period.
  • Adjusted operating margin was 21.1 percent.
  • The company expects third quarter organic sales to be down approximately 12 to 17 percent versus prior year.

Headline financials

Total Revenue

$561M

Previous: $642M-12.6%
EPS (adj)

$1.10

Previous: $1.50-26.7%
Capital Expenditures

-$21.1M

Previous: -$25.7M+18.1%
Free Cash Flow

$49.8M

Previous: $87.5M-43.1%
Net Income

$70.9M

Previous: $113M-37.4%
Operating Income

$111M

Previous: $155M-28.8%
Gross Profit

$235M

Previous: $292M-19.7%
Cash & Equivalents

$746M

Previous: $543M+37.4%
Total Assets

$4.07B

Previous: $3.64B+11.9%
Stock-Based Comp

$6.94M

Previous: $6.85M+1.2%

Revenue & EPS history

IDEX · Revenue · Quarterly

$561M

Q2 2020-12.6%vs Q2 2019
Beat estimate in 15 of 16 quarters(94%)
ActualEstimate

Revenue by segment

IDEX · $562M total across 3 segments · Q2 2020

  • Fluid & Metering Technologies
    $219M-11.0%
  • Health & Science Technologies
    $216M-7.1%
  • Fire & Safety/Diversified Products
    $127M-22.5%

Forward guidance

The company anticipates that organic sales will be down approximately 12 to 17 percent in the third quarter of 2020.

Headwinds

  • Uncertainty regarding the future path of the economy due to the evolving global pandemic.
  • Organic sales are expected to decline in the third quarter.
  • The global health pandemic continued to impact commercial performance.
  • Recent acquisitions negatively impacted adjusted gross margin and adjusted operating margin.
  • The company believes it hit the bottom in the second quarter, but faces much uncertainty.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

+0.2%

Avg return

Earnings day

+0.5%

Avg return

5 days after

+1.8%

Avg return

30 days after

57%

39 / 68 earnings

Positive

+8.4%

Q2 2018

Best reaction

-9.6%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.2%+4.4%+2.8%
Q4 2025+5.3%+4.5%-1.8%
Q3 2025+3.8%+0.8%+4.2%
Q1 2025+0.7%+3.2%+4.0%
Q4 2024-9.6%-10.2%-14.2%
Q3 2024+6.7%+5.5%+12.8%
Q2 2024-5.7%-7.6%-0.8%
Q1 2024-2.3%-4.0%-6.2%
Q4 2023+1.9%+4.6%+9.4%
Q3 2023+0.2%-1.1%+3.4%
Q2 2023+4.0%+7.3%+7.4%
Q1 2023-3.5%-4.0%-5.5%
Q4 2022-2.3%-1.4%-3.7%
Q3 2022+6.1%+7.6%+13.7%
Q2 2022+3.6%+8.2%+10.7%
Q1 2022+0.2%-1.0%-1.4%
Q4 2021-4.1%-8.3%-9.7%
Q3 2021+0.5%+0.6%+6.7%
Q2 2021-2.9%+0.2%-0.1%
Q1 2021-0.2%-0.6%-1.6%
Q4 2020-2.2%+2.4%+2.1%
Q3 2020-9.2%-10.4%+0.8%
Q2 2020-1.0%-2.3%+5.6%
Q1 2020+0.7%+4.0%-0.8%
Q4 2019-3.1%-3.6%-13.6%
Q3 2019-2.0%-0.2%+2.5%
Q2 2019+1.3%+1.9%-3.7%
Q1 2019-0.1%-0.0%-2.4%
Q4 2018+1.1%+1.8%+6.2%
Q3 2018-4.8%-4.6%-0.4%
Q2 2018+8.4%+9.1%+9.8%
Q1 2018-2.1%+0.0%+1.0%
Q4 2017+1.4%-0.2%-4.0%
Q3 2017-0.3%+1.0%+1.5%
Q2 2017+2.8%+2.4%-0.2%
Q1 2017+7.1%+9.2%+14.1%
Q4 2016-2.5%-1.6%+3.9%
Q3 2016+0.4%-0.1%+6.9%
Q2 2016+2.3%+2.4%+9.0%
Q1 2016+0.8%
Q4 2015-1.1%
Q3 2015-0.1%
Q2 2015+0.1%
Q1 2015+0.7%
Q4 2014-0.1%
Q3 2014+4.8%
Q2 2014+1.8%
Q1 2014+1.7%
Q4 2013+4.3%
Q3 2013+0.7%
Q2 2013+1.7%
Q1 2013+2.2%
Q4 2012-2.9%
Q3 2012+2.0%
Q2 2012-2.7%
Q1 2012-0.0%
Q4 2010-0.8%
Q4 2011-0.8%
Q3 2011-4.8%
Q2 2011-3.9%
Q1 2010-3.0%
Q1 2011+3.6%
Q4 2008+3.7%
Q3 2010+2.3%
Q3 2009+2.3%
Q2 2010+0.3%
Q2 2009+0.3%
Q4 2009+0.3%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro